Dysregulated soluble immune mediators and lupus-associated autoantibody specificities inform the development of immune indexes that characterise classified SLE transition and SLE disease activity

Source: https://lupus.bmj.com/content/12/2/e001753

Munroe ME, Young K, Lu R, Guthridge JM, Kamen DL, Gilkeson GS, et al. Dysregulated soluble immune mediators and lupus-associated autoantibody specificities inform the development of immune indexes that characterise classified SLE transition and SLE disease activity. Lupus Science & Medicine. 2025;12:e001753. https://doi.org/10.1136/lupus-2025-001753